Back to top

JANX Assumes by Truist Securities -- Price Target Lowered to $26

JANX Assumes by Truist Securities -- Price Target Lowered to $26

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Janux Therapeutics, Inc. (JANX)